SY2-4Development of Targeted Therapy for Advanced Non-Small Cell Lung Cancer With Rare Driver Oncogenes as RET or MET
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy363
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV